Clinical Trial Update: Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, pharmacokinetics, and the effect of food on DW5124 and DW5124-R in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Drugs mentioned

• DW5124
• DW5124-R

Snippet

Sponsor: Daewon Pharmaceutical Co., Ltd. | Conditions: Mixed Dyslipidemia | Phase 1 | Status: COMPLETED